Spots Global Cancer Trial Database for Tear Based Sample Collection Breast Cancer Detection
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tear Based Sample Collection Breast Cancer Detection
Official Title: Tear Based Sample Collection for Breast Cancer Detection
Study ID: NCT04974567
Interventions
Study Description
Brief Summary: This study aims to collect tear samples from 50 women who have been recently diagnosed with breast cancer.
Detailed Description: Namida Lab, Inc. is a biotechnology company located in Fayetteville, AR, with a certified, high-complexity CLIA lab. In January of 2021, Namida Lab, Inc. completed the analytical and clinical validation of a tear-based biological screening test for breast cancer based on proteins from tears. The validation process was carried out manually and now needs to be conducted on the Hamilton StarPlus automated ELISA system. To complete the robot validation, Namida Lab, Inc. needs fifty (50) tear samples collected from women recently diagnosed with breast cancer but who have not undergone any treatment.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
UTMB Health, Galveston, Texas, United States
Contact Details
Name: Suzanne Klimberg, MD, PhD
Affiliation: UTMB Health
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
